Funding · Company
AirNexis Therapeutics, Inc.
Palo Alto, CABiotech & Pharma
AirNexis Therapeutics, Inc. of Palo Alto, CA has disclosed $62M across 1 Form D offering filed with the SEC on Mar 9, 2026.
$62M
Total disclosed
1
Form D offering
3
Open roles today
Hiring — 3 open roles as of Sep 9, 2026
Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$62M
Form D · Mar 9, 2026 ↗
Q1 2026
· target $200M
Filing details
HeadquartersPalo Alto, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2024SEC CIK0002116194Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →